Your browser doesn't support javascript.
loading
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated ß-lactamase CMY-185 variant.
Shropshire, William C; Endres, Bradley T; Borjan, Jovan; Aitken, Samuel L; Bachman, William C; McElheny, Christi L; Wu, Chin-Ting; Egge, Stephanie L; Khan, Ayesha; Miller, William R; Bhatti, Micah M; Saharasbhojane, Pranoti; Kawai, Akito; Shields, Ryan K; Shelburne, Samuel A; Doi, Yohei.
Afiliação
  • Shropshire WC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Endres BT; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA.
  • Borjan J; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aitken SL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bachman WC; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McElheny CL; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Wu CT; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Egge SL; Program in Diagnostic Genetics and Genomics, MD Anderson Cancer Center School of Health Professions, Houston, TX, USA.
  • Khan A; Department of Internal Medicine, Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.
  • Miller WR; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
  • Bhatti MM; Department of Microbiology and Molecular Genetics, University of Texas Health Science Center, McGovern School of Medicine, Houston, TX, USA.
  • Saharasbhojane P; Department of Internal Medicine, Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.
  • Kawai A; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
  • Shields RK; Department of Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Doi Y; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
J Antimicrob Chemother ; 78(10): 2442-2450, 2023 10 03.
Article em En | MEDLINE | ID: mdl-37574665
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftazidima / Escherichia coli Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftazidima / Escherichia coli Idioma: En Ano de publicação: 2023 Tipo de documento: Article